1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 3813074 | 21217635 | Rat |
1581500 | Renag1 | Renal agenesis QTL 1 | | | kidney development trait (VT:0000527) | percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) | 14 | 8170668 | 68298175 | Rat |
731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 9088978 | 39057237 | Rat |
631212 | Bw5 | Body weight QTL5 | 5.43 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 14 | 11030812 | 30320092 | Rat |
2302277 | Gluco38 | Glucose level QTL 38 | 5.8 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 28035204 | Rat |
10755459 | Coatc15 | Coat color QTL 15 | | 0.01681 | coat/hair pigmentation trait (VT:0010463) | pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) | 14 | 19836944 | 64836944 | Rat |
1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 3813074 | 30767156 | Rat |
619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 32754612 | Rat |
1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 8267090 | 53267090 | Rat |
71117 | Niddm17 | Non-insulin dependent diabetes mellitus QTL 17 | 2.35 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 17593761 | 42336881 | Rat |
61420 | Pia6 | Pristane induced arthritis QTL 6 | 4.9 | | joint integrity trait (VT:0010548) | arthritic paw count (CMO:0001460) | 14 | 18631345 | 42337007 | Rat |
70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 3813074 | 24531477 | Rat |
2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
631839 | Niddm37 | Non-insulin dependent diabetes mellitus QTL 37 | 3.37 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 95876975 | Rat |
2313397 | Coatc1 | Coat color QTL1 | | | coat/hair pigmentation trait (VT:0010463) | coat/hair color measurement (CMO:0001808) | 14 | 18541332 | 63541332 | Rat |
631262 | Tcas4 | Tongue tumor susceptibility QTL 4 | 7.29 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 14 | 17622561 | 42337007 | Rat |
634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 41131407 | Rat |
2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 8267090 | 53267090 | Rat |
1300140 | Srn3 | Serum renin concentration QTL 3 | 3.19 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 14875168 | 30883947 | Rat |
2302371 | Stl22 | Serum triglyceride level QTL 22 | 5.15 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 57114705 | Rat |
1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 3813074 | 21217635 | Rat |
1358352 | Srcrt3 | Stress Responsive Cort QTL 3 | 2.29 | | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 38465774 | 146803430 | Rat |
61445 | Strs3 | Sensitivity to stroke QTL 3 | 3 | | cerebrum integrity trait (VT:0010549) | post-insult time to onset of cerebrovascular lesion (CMO:0002343) | 4 | 40433388 | 85433388 | Rat |
1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 3813074 | 30767156 | Rat |
10755501 | Bp390 | Blood pressure QTL 390 | 2.5 | | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 26775591 | 168368347 | Rat |
631839 | Niddm37 | Non-insulin dependent diabetes mellitus QTL 37 | 3.37 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 95876975 | Rat |
2313397 | Coatc1 | Coat color QTL1 | | | coat/hair pigmentation trait (VT:0010463) | coat/hair color measurement (CMO:0001808) | 14 | 18541332 | 63541332 | Rat |
2313401 | Anxrr27 | Anxiety related response QTL 27 | | | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 4 | 17933508 | 62933508 | Rat |
631209 | Bw2 | Body weight QTL2 | 4.2 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 4 | 9940885 | 44463908 | Rat |
6909128 | Pancm4 | Pancreatic morphology QTL 4 | 11.35 | | pancreas mass (VT:0010144) | pancreas wet weight (CMO:0000626) | 4 | 26907285 | 75585128 | Rat |
61475 | Aia2 | Adjuvant induced arthritis QTL 2 | 5.8 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 39505275 | 73892441 | Rat |
8694439 | Bw168 | Body weight QTL 168 | 9.57 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 4 | 40433414 | 85433414 | Rat |
1581500 | Renag1 | Renal agenesis QTL 1 | | | kidney development trait (VT:0000527) | percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) | 14 | 8170668 | 68298175 | Rat |
731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 9088978 | 39057237 | Rat |
631212 | Bw5 | Body weight QTL5 | 5.43 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 14 | 11030812 | 30320092 | Rat |
8655906 | Rf60 | Renal function QTL 60 | 3.8 | | blood creatinine amount (VT:0005328) | creatinine clearance (CMO:0000765) | 4 | 29494195 | 81006281 | Rat |
10755459 | Coatc15 | Coat color QTL 15 | | 0.01681 | coat/hair pigmentation trait (VT:0010463) | pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) | 14 | 19836944 | 64836944 | Rat |
7387227 | Uae40 | Urinary albumin excretion QTL 40 | 2.9 | 0.0052 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 4 | 17946999 | 62946999 | Rat |
6909122 | Insul22 | Insulin level QTL 22 | 4.63 | | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 4 | 26907285 | 75585128 | Rat |
70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 3813074 | 24531477 | Rat |
9590304 | Scort17 | Serum corticosterone level QTL 17 | 4.96 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 10084089 | 55084089 | Rat |
2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
1300139 | Hrtrt6 | Heart rate QTL 6 | 2.85 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 4 | 39524264 | 116179656 | Rat |
11530004 | Niddm71 | Non-insulin dependent diabetes mellitus QTL 71 | | 0.001 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 4 | 32584199 | 52754138 | Rat |
2316958 | Gluco58 | Glucose level QTL 58 | 10 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 11320076 | 180699135 | Rat |
1354665 | Stl10 | Serum triglyceride level QTL 10 | 3.57 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 21333343 | 44463908 | Rat |
1300140 | Srn3 | Serum renin concentration QTL 3 | 3.19 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 14875168 | 30883947 | Rat |
2303585 | Bw86 | Body weight QTL 86 | 4 | | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 14678065 | 59678065 | Rat |
8552906 | Pigfal3 | Plasma insulin-like growth factor 1 level QTL 3 | | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 10084089 | 55084089 | Rat |
8655949 | Rf62 | Renal function QTL 62 | 22 | | blood urea nitrogen amount (VT:0005265) | plasma urea nitrogen level (CMO:0000586) | 4 | 34430119 | 44463908 | Rat |
1331807 | Rf31 | Renal function QTL 31 | 2.988 | | urine potassium amount (VT:0010539) | urine potassium level (CMO:0000128) | 4 | 39524264 | 74726312 | Rat |
1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 8267090 | 53267090 | Rat |
71117 | Niddm17 | Non-insulin dependent diabetes mellitus QTL 17 | 2.35 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 17593761 | 42336881 | Rat |
6478766 | Anxrr47 | Anxiety related response QTL 47 | | 0.09637 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 4 | 10084089 | 55084089 | Rat |
8552782 | Vie1 | Viral induced encephalitis QTL 1 | 26.4 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 34430484 | 82490359 | Rat |
631642 | Stl2 | Serum triglyceride level QTL 2 | 3.3 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5219178 | 56647776 | Rat |
6478769 | Anxrr48 | Anxiety related response QTL 48 | | 0.02514 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 10084089 | 55084089 | Rat |
631261 | Tcas3 | Tongue tumor susceptibility QTL 3 | 6.88 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 4 | 10814170 | 91360527 | Rat |
631262 | Tcas4 | Tongue tumor susceptibility QTL 4 | 7.29 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 14 | 17622561 | 42337007 | Rat |
634323 | Hc2 | Hypercalciuria QTL 2 | 2.15 | | urine calcium amount (VT:0002985) | urine calcium excretion rate (CMO:0000763) | 4 | 210796 | 45210796 | Rat |
2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 26541967 | Rat |
8655961 | Kidm43 | Kidney mass QTL 43 | 18 | | kidney mass (VT:0002707) | both kidneys wet weight (CMO:0000085) | 4 | 36303261 | 103194984 | Rat |
8694374 | Bw155 | Body weight QTL 155 | 3.39 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 4 | 10084089 | 55084089 | Rat |
2303168 | Bp330 | Blood pressure QTL 330 | 4.25 | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 5214602 | 146446691 | Rat |
8552801 | Bw143 | Body weight QTL 143 | 7.3 | | body mass (VT:0001259) | change in body weight to body weight ratio (CMO:0002216) | 4 | 34430484 | 82490359 | Rat |
61412 | Pia2 | Pristane induced arthritis QTL 2 | 3.9 | | joint integrity trait (VT:0010548) | post-insult time to onset of experimental arthritis (CMO:0001450) | 4 | 21333343 | 62278020 | Rat |
2290374 | Gluco32 | Glucose level QTL 32 | 6.27 | | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 4 | 37177950 | 44463908 | Rat |
2302277 | Gluco38 | Glucose level QTL 38 | 5.8 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 11030622 | 28035204 | Rat |
6478724 | Anxrr35 | Anxiety related response QTL 35 | | 0.00449 | defecation behavior trait (VT:0010462) | defecation measurement (CMO:0000997) | 4 | 10084089 | 55084089 | Rat |
619616 | Bp79 | Blood pressure QTL 79 | | 0.0292 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 5214602 | 78882945 | Rat |
619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | urine total protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 32754612 | Rat |
8552809 | Vie5 | Viral induced encephalitis QTL 5 | 25.3 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 34430484 | 82490359 | Rat |
61420 | Pia6 | Pristane induced arthritis QTL 6 | 4.9 | | joint integrity trait (VT:0010548) | arthritic paw count (CMO:0001460) | 14 | 18631345 | 42337007 | Rat |
1358203 | Stl19 | Serum triglyceride level QTL 19 | 2.8 | 0.002 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 65958103 | Rat |
634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 41131407 | Rat |
12798520 | Anxrr55 | Anxiety related response QTL 55 | 4.45 | 0.01 | locomotor behavior trait (VT:0001392) | number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715) | 4 | 32583980 | 114627242 | Rat |
2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 8267090 | 53267090 | Rat |